My Friends House Family Counseling Services Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 371 Glassboro Rd, Woodbury Heights, NJ 08097 Phone: 856-669-6900 Fax: 856-384-0366 |
Newpoint Behavioral Health Care Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 343 Glassboro Rd, Building B Suite 104a, Woodbury Heights, NJ 08097 Phone: 856-845-8050 Fax: 856-845-6132 |
The Wounded Healer, Inc. D/b/a My Friends House Family Counseling Serv Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 371 Glassboro Road, Woodbury Heights, NJ 08097 Phone: 856-669-6900 Fax: 856-384-0366 |
Mfh Management Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 371 Glassboro Rd Ste 2, Woodbury Heights, NJ 08097 Phone: 856-669-6900 Fax: 856-384-0366 |
Your Serenity Wellness Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 371 Glassboro Rd Ste 1, Woodbury Heights, NJ 08097 Phone: 856-669-6900 |
Your Serentity Counseling Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 363 Glassboro Rd, Woodbury Heights, NJ 08097 Phone: 856-230-6251 |
Crossroads Treatment Center Of Woodbury Heights Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 40 Elm Ave, Woodbury Heights, NJ 08097 Phone: 800-805-6989 Fax: 864-558-8511 |
Acenda, Inc. Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 343 Glassboro Road, Bld B, Suite 102b, Woodbury Heights, NJ 08097 Phone: 844-422-3632 Fax: 856-881-5508 |
My Friends House Family Counseling Service Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 371 Glassboro Rd, Woodbury Heights, NJ 08097 Phone: 856-669-6900 |
My Friends House Medical Services, Inc. Counselor Medicare: Not Enrolled in Medicare Practice Location: 371 Glassboro Rd, Woodbury Heights, NJ 08097 Phone: 856-669-6900 Fax: 856-384-0366 |
News Archive
Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Patients with Parkinson's disease (PD) often have difficulties with visual acuity in low-contrast images. Because they may have normal high-contrast vision, this is often overlooked during routine eye exams. In the current issue of the Journal of Parkinson's Disease, researchers report that PD patients had significantly worse vision for low-contrast images at close (40 cm) and far (2 m) distances. Even for high-contrast images, PD patients' vision was deficient at far distances.
› Verified 8 days ago